Anja Dillenseger

479 total citations
18 papers, 279 citations indexed

About

Anja Dillenseger is a scholar working on Pathology and Forensic Medicine, Infectious Diseases and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Anja Dillenseger has authored 18 papers receiving a total of 279 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 3 papers in Infectious Diseases and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Anja Dillenseger's work include Multiple Sclerosis Research Studies (11 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Anja Dillenseger is often cited by papers focused on Multiple Sclerosis Research Studies (11 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Anja Dillenseger collaborates with scholars based in Germany, Switzerland and United Kingdom. Anja Dillenseger's co-authors include Tjalf Ziemssen, Rocco Haase, Katja Akgün, Isabel Voigt, Hernán Inojosa, Maria Scholz, Dirk Schriefer, Raimar Kern, Thomas Wilke and Undine Proschmann and has published in prestigious journals such as Science Advances, Frontiers in Immunology and Frontiers in Human Neuroscience.

In The Last Decade

Anja Dillenseger

16 papers receiving 268 citations

Peers

Anja Dillenseger
Xinyi Du-Harpur United Kingdom
Priyanka Gupta India
Dayoung Ko South Korea
Mohammed Imran Sajid United Kingdom
Birgit Ertl‐Wagner Canada
Giovanni Irmici Italy
Mert Karabacak United States
Daniel Zhao United States
Dong Hwan Kim South Korea
Elvira Lazić Mosler Croatia
Xinyi Du-Harpur United Kingdom
Anja Dillenseger
Citations per year, relative to Anja Dillenseger Anja Dillenseger (= 1×) peers Xinyi Du-Harpur

Countries citing papers authored by Anja Dillenseger

Since Specialization
Citations

This map shows the geographic impact of Anja Dillenseger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anja Dillenseger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anja Dillenseger more than expected).

Fields of papers citing papers by Anja Dillenseger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anja Dillenseger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anja Dillenseger. The network helps show where Anja Dillenseger may publish in the future.

Co-authorship network of co-authors of Anja Dillenseger

This figure shows the co-authorship network connecting the top 25 collaborators of Anja Dillenseger. A scholar is included among the top collaborators of Anja Dillenseger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anja Dillenseger. Anja Dillenseger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Inojosa, Hernán, et al.. (2025). Cost–consequence analysis of early vs. delayed natalizumab use in highly active relapsing–remitting multiple sclerosis: a simulation study. Journal of Neurology. 272(2). 153–153. 1 indexed citations
2.
Gilbert, Stephen, et al.. (2025). A roadmap for safe, regulation-compliant Living Labs for AI and digital health development. Science Advances. 11(20). eadv7719–eadv7719. 3 indexed citations
3.
Linz, Nicklas, Chris Chatham, James Overell, et al.. (2025). Speech as a digital biomarker in multiple sclerosis: Automatic analysis of speech metrics using a multi-speech-task protocol in a cross-sectional MS cohort study. Multiple Sclerosis Journal. 31(7). 856–865.
4.
Dias, Marcelo Fernandes Pacheco, Nicklas Linz, James Overell, et al.. (2024). Detecting fatigue in multiple sclerosis through automatic speech analysis. Frontiers in Human Neuroscience. 18. 1449388–1449388. 2 indexed citations
5.
Inojosa, Hernán, Dirk Schriefer, Anja Dillenseger, et al.. (2024). Insights from Real-World Practice: The Dynamics of SARS-CoV-2 Infections and Vaccinations in a Large German Multiple Sclerosis Cohort. Vaccines. 12(3). 265–265. 2 indexed citations
6.
Proschmann, Undine, et al.. (2023). Differential effects of selective versus unselective sphingosine 1-phosphate receptor modulators on T- and B-cell response to SARS-CoV-2 vaccination. Multiple Sclerosis Journal. 29(14). 1849–1859. 8 indexed citations
7.
Rouzic, Erwan Muros‐Le, Anja Dillenseger, Ulf Maywald, et al.. (2023). Claims-based algorithm to estimate the Expanded Disability Status Scale for multiple sclerosis in a German health insurance fund: a validation study using patient medical records. Frontiers in Neurology. 14. 1253557–1253557. 1 indexed citations
8.
Dillenseger, Anja, et al.. (2023). Long-Term Immune Response Profiles to SARS-CoV-2 Vaccination and Infection in People with Multiple Sclerosis on Anti-CD20 Therapy. Vaccines. 11(9). 1464–1464. 5 indexed citations
9.
Dillenseger, Anja, et al.. (2023). Data Resource Profile: The Multiple Sclerosis Documentation System 3D and AOK PLUS Linked Database (MSDS-AOK PLUS). Journal of Clinical Medicine. 12(4). 1441–1441. 1 indexed citations
10.
11.
12.
13.
Dillenseger, Anja, Hernán Inojosa, Rocco Haase, et al.. (2021). Digital Biomarkers in Multiple Sclerosis. Brain Sciences. 11(11). 1519–1519. 68 indexed citations
14.
Voigt, Isabel, Hernán Inojosa, Anja Dillenseger, et al.. (2021). Digital Twins for Multiple Sclerosis. Frontiers in Immunology. 12. 669811–669811. 149 indexed citations
15.
Haase, Rocco, Isabel Voigt, Maria Scholz, et al.. (2021). Profiles of eHealth Adoption in Persons with Multiple Sclerosis and Their Caregivers. Brain Sciences. 11(8). 1087–1087. 11 indexed citations
16.
Mückschel, Moritz, Anja Dillenseger, Christoph Lange, et al.. (2020). On the Reliability of Examining Dual-Tasking Abilities Using a Novel E-Health Device—A Proof of Concept Study in Multiple Sclerosis. Journal of Clinical Medicine. 9(11). 3423–3423. 1 indexed citations
17.
Dillenseger, Anja & Tjalf Ziemssen. (2020). "Miss alles, was sich messen lässt". DNP - Der Neurologe und Psychiater. 21(4). 37–41.
18.
Haase, Rocco, et al.. (2018). Improving multiple sclerosis management and collecting safety information in the real world: the MSDS3D software approach. Expert Opinion on Drug Safety. 17(4). 369–378. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xinyi Du-Harpur Breakdown of academic impact, for papers by Priyanka Gupta Breakdown of academic impact, for papers by Dayoung Ko Breakdown of academic impact, for papers by Mohammed Imran Sajid Breakdown of academic impact, for papers by Birgit Ertl‐Wagner Breakdown of academic impact, for papers by Giovanni Irmici Breakdown of academic impact, for papers by Mert Karabacak Breakdown of academic impact, for papers by Daniel Zhao Breakdown of academic impact, for papers by Dong Hwan Kim Breakdown of academic impact, for papers by Elvira Lazić Mosler
Rankless by CCL
2026